Y-mAbs Therapeutics Inc (YMAB)
11.56
-0.29
(-2.45%)
USD |
NASDAQ |
May 17, 16:00
11.56
0.00 (0.00%)
After-Hours: 20:00
Y-mAbs Therapeutics Cash from Financing (Quarterly): 0.588M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.588M |
| December 31, 2023 | 0.10M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.052M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.032M |
| December 31, 2021 | 0.10M |
| September 30, 2021 | 0.248M |
| June 30, 2021 | 0.131M |
| March 31, 2021 | 107.84M |
| Date | Value |
|---|---|
| December 31, 2020 | 1.419M |
| September 30, 2020 | 0.215M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.37M |
| December 31, 2019 | 134.70M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -1.842M |
| September 30, 2018 | 102.37M |
| June 30, 2018 | -0.127M |
| March 31, 2018 | -1.641M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
134.70M
Maximum
Dec 2019
12.29M
Average
0.076M
Median
Cash from Financing (Quarterly) Benchmarks
| The Cooper Companies Inc | 212.30M |
| Puma Biotechnology Inc | 0.00 |
| Humacyte Inc | 62.80M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.477M |
| Free Cash Flow | -17.58M |
| Free Cash Flow Per Share (Quarterly) | -0.0794 |
| Free Cash Flow to Equity (Quarterly) | -3.477M |
| Free Cash Flow to Firm (Quarterly) | -3.477M |
| Free Cash Flow Yield | -3.47% |